| Q30475205 | A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment |
| Q34363811 | Amnesia of inhibitory avoidance by scopolamine is overcome by previous open-field exposure |
| Q30310747 | Anti-parkinsonian agents procyclidine and ethopropazine alleviate thermal hyperalgesia in neuropathic rats |
| Q41681506 | Behavioral side effects of prophylactic therapies against soman-induced seizures and lethality in rats |
| Q30576082 | Blockade of muscarinic receptors impairs the retrieval of well-trained memory. |
| Q48620450 | Decreased prepulse inhibition and increased sensitivity to muscarinic, but not dopaminergic drugs in M5 muscarinic acetylcholine receptor knockout mice. |
| Q24670438 | Delta opioid receptor ligands modulate anxiety-like behaviors in the rat |
| Q47638973 | Effect of Scopolamine on Mice Motor Activity, Lick Behavior and Reversal Learning in the IntelliCage. |
| Q34088561 | Effects of MDL 73005 on water-maze performances and locomotor activity in scopolamine-treated rats |
| Q43938375 | Effects of selected anticholinergics on acoustic startle response in rats |
| Q42755733 | Electromyographic evidence in support of a knock-in mouse model of DYT1 Dystonia |
| Q43662847 | Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. |
| Q30405597 | Locomotor activating effects of cocaine and scopolamine combinations in rats: isobolographic analysis |
| Q46251071 | Muscarinic receptor blockade in ventral hippocampus and prelimbic cortex impairs memory for socially transmitted food preference |
| Q40468311 | Perirhinal cortex muscarinic receptor blockade impairs taste recognition memory formation. |
| Q30457634 | Reversal of scopolamine-induced disruption of prepulse inhibition by clozapine in mice |
| Q46514322 | Safety pharmacology assessment of central nervous system function in juvenile and adult rats: effects of pharmacological reference compounds |
| Q33999521 | Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor. |
| Q44663193 | The influence of diazepam on atropine reversal of behavioural impairment in dichlorvos-treated rats |
| Q35545032 | The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats |
| Q92093313 | The non-receptor tyrosine kinase Pyk2 modulates acute locomotor effects of cocaine in D1 receptor-expressing neurons of the nucleus accumbens |
| Q34301403 | The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats |
| Q46440592 | Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be reversed by cognitive enhancers but not by antipsychotic drugs |
| Q33688727 | Vitamin C deficiency increases basal exploratory activity but decreases scopolamine-induced activity in APP/PSEN1 transgenic mice |